Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry. Theodorsdottir A, Debrabant B, Magyari M, Kant M, et al. Mult Scler 2021 Mar 29:13524585211003291. doi: 10.1177/13524585211003291.

Read + Share

Amedeo Smart

Independent Medical Education

Theodorsdottir A, Debrabant B, Magyari M, Kant M, et al. Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry. Mult Scler 2021 Mar 29:13524585211003291. doi: 10.1177/13524585211003291.
PMID: 33779361